Results 201 to 210 of about 104,643 (306)

Methadone [PDF]

, 2005
Arthur G. Lipman
openalex   +1 more source

Analysis of rapid onset heroin overdose cases from a supervised injecting facility in Melbourne, Australia

Addiction, Volume 121, Issue 2, Page 296-304, February 2026.
Abstract Aims To characterise the clinical condition of rapid onset heroin overdose cases, and to determine the incidence and characteristics of such cases. Design A retrospective cohort study of witnessed heroin overdose cases over a 12‐month period (1 July 2023 to 30 June 2024). Setting The Medically Supervised Injecting Room in Melbourne, Australia.
Nathan C. Stam, Monika Shrestha, Basak Tas, John Furler, Yvonne Bonomo, John Strang   +5 more
wiley   +1 more source

Impacts of Disruptive Events on Addictive Behavioral Patterns: A Cross-Sectional Study of Methadone Maintenance Therapy During the COVID-19 Pandemic in Iran. [PDF]

Health Sci Rep
Toreyhi Z, Rezai-Mersagh AM, Kheradmand A, Mehrvar R.   +3 more
europepmc   +1 more source

Methadone patients in the therapeutic community: A test of equivalency

, 2008
James L. Sorensen, Siara Andrews, Kevin Delucchi, Brian Greenberg, Joseph Guydish, Carmen L. Masson, Michael S. Shopshire   +6 more
openalex   +1 more source

Perspectives on addiction‐related problems in Vietnam

Addiction, Volume 121, Issue 2, Page 448-457, February 2026.
Abstract The article provides an overview of key substance use and addictive behaviors in Vietnam, alongside the development of addiction science, drawing from a synthesis of literature and the authors' perspectives. Over the last two decades, the primary illicit drug of concern has shifted from heroin to methamphetamine and other psychoactive ...
Nguyen Thu Trang, Nguyen Bich Diep, Phong K. Thai, Nguyen Cuu Duc, Le Minh Giang   +4 more
wiley   +1 more source

Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats

British Journal of Pharmacology, Volume 183, Issue 3, Page 505-519, February 2026.
Background and Purpose Riluzole, approved for amyotrophic lateral sclerosis (ALS), has a glutamate‐modulating profile favourable for mitigating opioid addiction. It reduces neuronal glutamate release and enhances glutamate reuptake, offering advantages over agents that only increase glutamate reuptake.
Ewa Galaj, Saadet Inan, Guo‐Hua Bi, Sonita Wiah, George Adamson, Allen B. Reitz, Zheng‐Xiong Xi, Scott M. Rawls   +7 more
wiley   +1 more source

Exploring the effects of cannabidiol on pain sensitivity using quantitative sensory testing among individuals receiving methadone or buprenorphine for opioid use disorder: an open-label, proof-of-concept study. [PDF]

Addict Behav Rep
Costa GPA, Suh R, Sofuoglu M, De Aquino JP.   +3 more
europepmc   +1 more source

Perceived Barriers and Potential Strategies for People Who Use Drugs in Accessing Oral Healthcare: A Qualitative Study of Service Providers

Community Dentistry and Oral Epidemiology, Volume 54, Issue 1, Page 112-125, February 2026.
ABSTRACT Objective Access to appropriate oral healthcare is vital for overall health and well‐being. However, people who use drugs (PWUD) often face significant barriers in accessing oral healthcare services. This qualitative study focused on exploring the perspectives of public oral health service providers and harm reduction workers to understand the
Tejashree Kangutkar, Mark Gussy, Ronald Knevel, Hanny Calache   +3 more
wiley   +1 more source

Geographic differences in buprenorphine and methadone prescribing for surgical patients with opioid use disorder. [PDF]

Drug Alcohol Depend Rep
Coates CP, Carroll MM, Richard JM, Craig WY, Quaye AN.   +4 more
europepmc   +1 more source

Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations [PDF]

, 2011
Bunten, Hannah, Liang, Wei-Jun, Osselton, David M., Pounder, Derrick   +3 more
core